Search research articles
Contact Us
Filters
Showing results (191-200 of 216) with videos related to
Page
of 22
Sort By:
Ejhaem
|
September 5, 2020
Prognostic plasma biomarkers of early complications and graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation
Balaji Balakrishnan, Raveen Stephen Stallon Illangeswaran, Bharathi M Rajamani, et al.
Blood Cancer Journal
|
February 1, 2022
Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia
Uday P Kulkarni, Sushil Selvarajan, Sharon Lionel, et al.
Science Translational Medicine
|
May 8, 2024
The translational gap for gene therapies in low- and middle-income countries
Kevin W Doxzen, Jennifer E Adair, Yris Maria Fonseca Bazzo, et al.
Blood
|
February 27, 2019
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel A Sanz, Pierre Fenaux, Martin S Tallman, et al.
British Journal of Haematology
|
March 3, 2021
Outcomes in adolescent and young adult acute lymphoblastic leukaemia: a report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)
Prasanth Ganesan, Hasmukh Jain, Bhausaheb Bagal, et al.
Plos One
|
March 31, 2015
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance
Ezhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex, et al.
Scientific Reports
|
November 27, 2020
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients
Bharathi M Rajamani, Esther Sathya Bama Benjamin, Aby Abraham, et al.
Blood Cells, Molecules & Diseases
|
January 25, 2023
Hematologically important mutations: Leukocyte adhesion deficiency (second update)
Dirk Roos, Karin van Leeuwen, Manisha Madkaikar, et al.
American Journal of Hematology
|
April 9, 2014
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up
Carlo Gambacorti-Passerini, Tim H Brümmendorf, Dong-Wook Kim, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
March 27, 2015
Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
M B Agarwal, Hemant Malhotra, Prantar Chakrabarti, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 216) with videos related to
Sort By:
Page
of 22
Ejhaem
|
September 5, 2020
Prognostic plasma biomarkers of early complications and graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation
Balaji Balakrishnan, Raveen Stephen Stallon Illangeswaran, Bharathi M Rajamani, et al.
Blood Cancer Journal
|
February 1, 2022
Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia
Uday P Kulkarni, Sushil Selvarajan, Sharon Lionel, et al.
Science Translational Medicine
|
May 8, 2024
The translational gap for gene therapies in low- and middle-income countries
Kevin W Doxzen, Jennifer E Adair, Yris Maria Fonseca Bazzo, et al.
Blood
|
February 27, 2019
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel A Sanz, Pierre Fenaux, Martin S Tallman, et al.
British Journal of Haematology
|
March 3, 2021
Outcomes in adolescent and young adult acute lymphoblastic leukaemia: a report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)
Prasanth Ganesan, Hasmukh Jain, Bhausaheb Bagal, et al.
Plos One
|
March 31, 2015
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance
Ezhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex, et al.
Scientific Reports
|
November 27, 2020
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients
Bharathi M Rajamani, Esther Sathya Bama Benjamin, Aby Abraham, et al.
Blood Cells, Molecules & Diseases
|
January 25, 2023
Hematologically important mutations: Leukocyte adhesion deficiency (second update)
Dirk Roos, Karin van Leeuwen, Manisha Madkaikar, et al.
American Journal of Hematology
|
April 9, 2014
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up
Carlo Gambacorti-Passerini, Tim H Brümmendorf, Dong-Wook Kim, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
March 27, 2015
Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
M B Agarwal, Hemant Malhotra, Prantar Chakrabarti, et al.
Page
of 22